Pharmaceutics_R&D
Follow
Find tag "Novartis"
3.7K views | +0 today
Pharmaceutics_R&D
Pharmaceutical companies R&D specifically in neuroscience, CNS disease, pain and electrophysiology
Your new post is loading...
Your new post is loading...
Scooped by Julien Hering, PhD
Scoop.it!

Novartis reboots brain division

Novartis reboots brain division | Pharmaceutics_R&D | Scoop.it
After years in the doldrums, research into neurological disorders is about to undergo a major change of direction.

In a sign that psychiatric-disease research is entering a new era, the pharmaceutical giant Novartis has hired an expert in neural circuitry, rather than pharmacology, to head its relaunched neuroscience division. (...) - by Alison Abbot, Nature, 08 October 2013

more...
Magdalena Kawalec's curator insight, November 25, 2013 7:01 AM

Good decission. Befor to decide "how to design it" maybe better to know "how it works in the first place"

Scooped by Julien Hering, PhD
Scoop.it!

Novartis CEO: The Age Of Massive Blockbuster Drugs Is Over

Novartis CEO: The Age Of Massive Blockbuster Drugs Is Over | Pharmaceutics_R&D | Scoop.it

Big pharma needs to change its whole business model.


The business model for large pharmaceutical companies hasn't changed for decades.


You target a huge population, like people with heart disease, find and patent a drug that's at least marginally better than current treatments, and make billions. It's worked pretty well for a long time. (..) - by Max Nisen, Business Insider, Mar. 4, 2013

more...
No comment yet.
Scooped by Julien Hering, PhD
Scoop.it!

4 Key Drug Approvals Expected In The Next 30 Days

4 Key Drug Approvals Expected In The Next 30 Days | Pharmaceutics_R&D | Scoop.it

Biogen Idec's BG-12, United Therapeutics' oral Remodulin, Johnson & Johnson's Invokana and Allergan's Levadex are all nearing their possible launches

Investing in drug stocks isn't quite like investing in other stocks. While drugmakers' shares can move on earnings and buyout news like anyone else's, what really gets investors excited is an FDA decision allowing a new drug on the market. Here are some of the most important drugs awaiting approval in the next month. (...) - by Amy Reeves, Investors.com, 03/15/2013

more...
No comment yet.